
Under normal market conditions, the fund pursues its objective by investing at least 80% of its net assets (including any borrowings for investment purposes) in equity securities of companies based in the United States. It invests primarily in equity securities (generally common and preferred stocks) of large U.S. companies. The Adviser uses a proprietary quantitative three factor model designed to select up to 50 stocks from the Russell 3000 Index.
FormulaFolios US Equity Fund Investor Class trades as FFIOX on NASDAQ. The company is classified in Financial Services / Asset Management and reports in USD.
The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Detailed operating-segment data is not available for this symbol yet.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
FormulaFolios US Equity Fund Investor Class can be compared against peers such as AQR TM Small Cap Momentum Style Fund Class I, Columbia Select Global Growth Fund Institutional 2 Class, Columbia Select Global Growth Fund Class R, EA Series Trust - Matrix Advisors Value ETF, BNY Mellon Focused Equity Opportunities Fund Investor Shares, Manning & Napier Target 2025 Series Class I.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $70.36M, beta of 0.72, and return on equity of N/A.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
FFIOX currently shows total debt of N/A and beta of 0.72. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
Recent filings to review: N-CSR (2026-06-05 00:00:00), 485APOS (2026-06-01 00:00:00), DEFA14A (2026-05-29 00:00:00), NPORT-P (2026-05-28 00:00:00).
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website is not available.
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.